Kitasamycin
Clinical data | |
---|---|
Other names | Turimycin |
AHFS/Drugs.com | International Drug Names |
ATCvet code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C35H59NO13 |
Molar mass | 701.851 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Kitasamycin (INN) is a macrolide antibiotic. It is produced by Streptomyces kitasatoensis.[1] The drug has antimicrobial activity against a wide spectrum of pathogens. There are several generic names of this drug such as:[2]
- Kitasamycin (OS: BAN, JAN, USAN)
- Kitasamycine (OS: DCF)
- C 637 (IS)
- Katasamycin (IS)
- Leucomycin (IS)
- Kitasamycin (PH: JP XV)
- Kitasamycin Acetate (OS: JAN)
- Leucomycin Acetate (IS)
- Kitasamycin Acetate (PH: JP XV)
- Kitasamycin Tartrate (OS: JAN)
- Leucomycin Tartrate (IS)
- Kitasamycin Tartrate (PH: JP XV)
References
- ↑ Zheng Q, Gao S (November 2016). "The effect of surfactant on fermentation of kitasamycin in Streptomyces kitasatoensis". Biotechnology and Applied Biochemistry. 63 (6): 895–900. doi:10.1002/bab.1443. PMID 26339801.
- ↑ "Kitasamycin". Drugs.com. Archived from the original on 20 October 2012.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.